Erratum: Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: Resveratrol, tyrosol, and hydroxytyrosol (Journal of Agricultural and Food Chemistry (2008) 56: 20 (9362-9373) DOI: 10.1021/jf801791d);Does white wine qualify for French paradox? Comparison of the cardioprotective effects of red and white wines and their constituents: Resveratrol, tyrosol, and hydroxytyrosol

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 20, 2008, Pages 9362-9373

  Dudley, Jocelyn I ^a   Lekli, Istvan ^a   Mukherjee, Subhendu ^a   Das, Manika ^a   Bertelli, Alberto A A ^b   Das, Dipak K ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Hydroxytyrosol; Ischemia reperfusion; Mitochondrial swelling; Peroxide formation; Red wine; Resveratrol; Tyrosol; White wine

Indexed keywords

RATTUS;

EID: 55549119303     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf3008597     Document Type: Erratum

References (50)

1. Renaud, S. L.; de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339, 1523-1526.
2. Cui, J.; Tosaki, A.; Cordis, G. A.; Bertelli, A. A.; Bertelli, A.; Maulik, N.; Das, D. K. Cardioprotective abilities of white wine. Ann. N.Y. Acad. Sci. 2002, 957, 308-316.
3. Bertelli, A. A. E.; Migliori, M.; Panichi, V.; Longoni, B.; Origlia, N.; Ferretti, A.; Cuttano, M. G.; Giovannini, L. Oxidative stress and inflammatory reaction modulation by white wine. Ann. N.Y. Acad. Sci. 2002, 957, 295-301.
4. Vázquez-Agell, M.; Sacanella, E.; Tobias, E.; Monagas, M.; Antúnez, E.; Zamora-Ros, R.; Andrés-Lacueva, C.; Lamuela-Raventós, R. M.; Fernández-Solá, J.; Nicolás, J. M.; Estruch, R. Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J. Nutr. 2007, 137 (10), 2279-2284.
5. Cui, J.; Tosaki, A.; Bertelli, A. A.; Bertelli, A.; Maulik, N.; Das, D. K. Cardioprotection with white wine. Drugs. Exp. Clin. Res. 2002, 28 (1), 1-10.
6. Covas, M. I.; Miró-Casas, E.; Fitó, M.; Farré-Albadalejo, M.; Gimeno, E.; Marrugat, J.; De La Torre, R. Bioavailability of tyrosol, an antioxidant phenolic compound present in wine and olive oil, in humans. Drugs Exp. Clin. Res. 2003, 29 (5-6), 203-206.
7. Becker, L. B. New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc. Res. 2004, 61, 461-470.
8. Ambrosio, G.; Zweier, J. L.; Duilio, C.; Kuppusamy, P.; Santoro, G.; Elia, P. P.; Tritto, I.; Cirillo, P.; Condorelli, M.; Chiariello, M.; Flahertyj, J. T. Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. J. Biol. Chem. 1993, 268, 18532-18541.
9. Zhao, X.; He, G.; Chen, Y. R.; Pandian, R. P.; Kuppusamy, P.; Zweier, J. L. Endothelium-derived nitric oxide regulates postischemic myocardial oxygenation and oxygen consumption by modulation of mitochondrial electron transport. Circulation 2005, 111, 2966-2972.
10. Petrosillo, G.; Ruggiero, F. M.; Di Venosa, N.; Paradies, G. Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J. 2003, 17 (6), 714-716.
11. Chen, Y. R.; Chen, C. L.; Pfeiffer, D. R.; Zweier, J. L. Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation. J. Biol. Chem. 2007, 282, 32640-32654.
12. Rouslin, W. Mitochondrial complexes I, II, III, IV, and V in myocardial ischemia and autolysis. Am. J. Physiol. 1983, 244, H743-H748.
13. Mukherjee, S.; Gangopadhyay, H.; Das, D. K. Broccoli: a unique vegetable that protects mammalian hearts through the redox cycling of the thioredoxin superfamily. J. Agric. Food Chem. 2008, 56 (2), 609-617.
14. Das, M.; Parker, J. E.; Halestrap, A. P. Matrix volume measurements challenge the existence of diazoxide/glibencamide-sensitive KATP channels in rat mitochondria. J. Physiol. 2003, 547 (Pt 3), 893-902.
15. Clark, J. B.; Bates, T. E.; Boakye, P.; Kuimov, A. L. J. M. Investigation of mitochondrial defects in brain and skeletal muscle. In Neurochemistry: A Practical Approach; Turner, A. J., Bachelard, H. S., Eds.; Oxford University Press: New York, 1997; pp 151-174.
16. Robinson, K. M.; Lemire, B. D. Flavinylation of succinate: ubiquinone oxidoreductase from Saccharomyces cerevisiae. Methods Enzymol. 1995, 260, 34-51.
17. Sherwood, S.; Hirst, J. Investigation of the mechanism of proton translocation by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria: does the enzyme operate by a Q-cycle mechanism? Biochem. J. 2006, 400 (3), 541-550.
18. Briet, F.; Jeejeebhoy, K. N. Effect of hypoenergetic feeding and refeeding on muscle and mononuclear cell activities of mitochondrial complexes I-IV in enterally fed rats. Am. J. Clin. Nutr. 2001, 73 (5), 975-983.
19. Fremont, L. Biological effects of resveratrol. Life Sci. 2001, 66, 663-673.
20. Hall, S. S. Longevity research. In vino vitalis? Compounds activate life extending genes. Science 2003, 301 (5637), 1165.
21. Gaziano, J. M.; Buring, J. E.; Breslow, J. L.; Goldhaber, S. Z.; Rosner, B.; VanDenburgh, M.; Willett, W.; Hennekens, C. H. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial. N. Engl. J. Med. 1993, 329, 1829-1834.
22. Renaud, S. C.; Beswick, A. D.; Fehily, A. M.; Sharp, D. S.; Elwood, P. C. Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am. J. Clin. Nutr. 1992, 55, 1012-1017.
23. Veenstra, J.; Kluft, C.; Ockhuizen, T. H.; van der Pol, H.; Wedel, M.; Schaafsma, G. Effects of moderate alcohol consumption on platelet function, tissue-type plasminogen activator and plasminogen activator inhibitor. Thromb. Haemostasis 1990, 63, 345-348.
24. Demrow, H. S.; Slane, P. R.; Folts, J. D. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation 1995, 91, 1182-1188.
25. Frankel, E. N.; Kanner, J.; German, J. B.; Parks, E.; Kinsella, J. E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993, 341, 454-457.
26. Fauconneau, B.; Waffo-Teguo, P.; Huguet, F.; Barrier, L.; Decendit, A.; Merillon, J. M. Comparative study of radical scavengerand antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests. Life Sci. 1997, 61, 2103-2110.
27. Siemann, E. H.; Creasy, L. L. Concentration of the phytoalexin resveratrol in wine. Am. J. Enol. Vitic. 1992, 43, 49-52.
28. Jeandet, P.; Bessis, R.; Sbaghi, M.; Meunier, P.; Trollat, P. Resveratrol content of wines of different ages: relationship with fungal disease pressure in the vineyard. Am. J. Enol. Vitic. 1995, 46, 1-4.
29. Hattori, R.; Otani, H.; Maulik, N.; Das, D. K. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am. J. Physiol. Heart Circ. Physiol. 2002, 282 (6), H1988-H1995.
30. Naderali, E. K.; Doyle, P. J.; Williams, G. Resveratrol induces vasorelaxation of mesenteric and uterine arteries from female guinea-pigs. Clin. Sci. 2000, 98, 537-543.
31. Falchi, M.; Bertelli, A.; Lo Scalzo, R.; Morassut, M.; Morelli, R.; Das, S.; Cui, J.; Das, D. K. Comparison of cardioprotective abilities between the flesh and skin of grapes. J. Agric. Food Chem. 2006, 54, 6613-6622.
32. Visioli, F.; Bellomo, G.; Montedoro, G.; Galli, C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis 1995, 117, 25-32.
33. Petroni, A.; Blasevich, M.; Salami, M.; Papini, G. F.; Montedoro, G. F.; Galli, C. Inhibition of platelet aggregation and eicosanoid production by phenolic components of olive oil. Thromb. Res. 1995, 78, 151-160.
34. Carluccio, M. A.; Siculella, L.; Ancora, M. A.; Massaro, M.; Scoditti, E.; Storelli, C.; Visioli, F.; Distante, A.; De Caterina, R. Olive oil and red wine antioxidant polyphenols inhibit endothelial activation: antiatherogenic properties of Mediterranean diet phytochemicals. Arterioscler. Thromb. Vasc. Biol. 2003, 23 (4), 622-629.
35. Javadov, S.; Choi, A.; Rajapurohitam, V.; Zeidan, A.; Basnakian, A. G.; Karmazyn, M. NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition. Cardiovasc. Res. 2008, 77 (2), 416-424.
36. Gustafsson, A. B.; Gottlieb, R. A. Heart mitochondria: gates of life and death. Cardiovasc. Res. 2008, 77 (2), 334-343.
37. Tong, H.; Chen, W.; Steenbergen, C.; Murphy, E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ. Res. 2000, 87, 309-315.
38. Matsui, T.; Tao, J.; del Monte, F.; Lee, K. H.; Li, L.; Picard, M.; Force, T. L.; Franke, T. F.; Hajjar, R. J.; Rosenzweig, A. Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo. Circulation 2001, 104, 330-335.
39. Miao, W.; Luo, Z.; Kitsis, R. N.; Walsh, K. Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. J. Mol. Cell. Cardiol. 2000, 32, 2397-2402.
40. Majewski, N.; Nogueira, V.; Robey, R. B.; Hay, N. Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases. Mol. Cell. Biol. 2004, 24, 730-740.
41. Plas, D. R.; Talapatra, S.; Edinger, A. L.; Rathmell, J. C.; Thompson, C. B. Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology. J. Biol. Chem. 2001, 276, 2041-2048.
42. Datta, S. R.; Dudek, H.; Tao, X.; Masters, S.; Fu, H.; Gotoh, Y.; Greenberg, M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91, 231-241.
43. Tsuruta, F.; Masuyama, N.; Gotoh, Y. The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 2002, 277, 14040-14047.
44. Gustafsson, A. B.; Gottlieb, R. A. Bcl-2 family members and apoptosis, taken to heart. Am. J. Physiol. Cell. Physiol. 2006, 292, C45-C51.
45. Zhu, L.; Yu, Y.; Chua, B. H.; Ho, Y. S.; Kuo, T. H. Regulation of sodium-calcium exchange and mitochondrial energetics by Bcl-2 in the heart of transgenic mice. J. Mol. Cell. Cardiol. 2001, 33, 2135-2144.
46. Imahashi, K.; Schneider, M. D.; Steenbergen, C.; Murphy, E. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res. 2004, 95, 734-741.
47. Rouslin, W.; Erickson, J. L.; Solaro, R. J. Effects of oligomycin and acidosis on rates of ATP depletion in ischemic heart muscle. Am. J. Physiol. 1986, 250, H503-H508.
48. Huang, J.; Nakamura, K.; Ito, Y.; Uzuka, T.; Morikawa, M.; Hirai, S.; Tomihara, K.; Tanaka, T.; Masuta, Y.; Ishii, K.; Kato, K.; Hamada, H. Bcl-xL gene transfer inhibits Bax translocation and prolongs cardiac cold preservation time in rats. Circulation 2005, 112, 76-83.
49. Hattori, R.; Otani, H.; Maulik, N.; Das, D. K. Pharmacological preconditioning with resveratrol: role of nitric oxide. Am. J. Physiol. Heart. Circ. Physiol. 2002, 282, H1988-H1995.
50. Thirunavukkarasu, M.; Penumathsa, S. V.; Koneru, S.; Juhasz, B.; Zhan, L.; Otani, H.; Bagchi, D.; Das, D. K.; Maulik, N. Resveratrol alleviates cardiac dysfunction in streptozotocin induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radical Biol. Med. 2007, 43 (5), 720-729.